Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 12/20 | 0.67 |
| ▸ | RET | P07949 | 4/20 | 0.67 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.67 |
| ▸ | PLK4 | O00444 | 1/20 | 0.67 |
| ▸ | GAK | O14976 | 1/20 | 0.67 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.67 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.67 |
| ▸ | ERN1 | O75460 | 1/20 | 0.67 |
| ▸ | STK10 | O94804 | 1/20 | 0.67 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.67 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.67 |
| ▸ | ABL1 | P00519 | 1/20 | 0.67 |
| ▸ | EGFR | P00533 | 1/20 | 0.67 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.67 |
| ▸ | LCK | P06239 | 1/20 | 0.67 |
| ▸ | FYN | P06241 | 1/20 | 0.67 |
| ▸ | CSF1R | P07333 | 1/20 | 0.67 |
| ▸ | YES1 | P07947 | 1/20 | 0.67 |
| ▸ | LYN | P07948 | 1/20 | 0.67 |
| ▸ | MET | P08581 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4433298 | 0.95 | KDR (0.68) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL1401640 | 0.88 | KDR (0.65) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL6366685 | 0.86 | KDR (0.49) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL16693713 | 0.84 | KDR (0.76) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL15966394 | 0.84 | KDR (0.76) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL665691 | 0.84 | KDR (0.73) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL664923 | 0.83 | KDR (0.63) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL3201243 | 0.83 | KDR (0.73) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL1401711 | 0.83 | KDR (0.75) | KDRRETPDGFRBPLK4GAK | |
| SCHEMBL296675 | 0.83 | KDR (0.75) | KDRRETPDGFRBPLK4GAK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132184-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | AstraZeneca AB (SE) | 2009-12-16 | — | — | EP | claimed |
| WO-2008104754-A1 | NOVEL PYRIMIDINE DERIVATIVES 698 | ASTRAZENECA AB (SE) | 2008-09-04 | — | — | WO | claimed |
| EP-4079735-B1 | MACROCYCLIC COMPOUNDS FOR INHIBITING AND INDUCING DEGRADATION OF EGFR KINASE IN THE TREATMENT OF CANCER | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024092151-A1 | DIRECT MEASUREMENT OF ENGINEERED CANCER MUTATIONS AND THEIR TRANSCRIPTIONAL PHENOTYPES IN SINGLE CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023212293-A1 | COMPLEMENT FACTOR H RELATED 4-SPECIFIC ANTIBODIES AND USES THEREOF | BROADWING BIO LLC (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023212294-A1 | ANGIOPOIETIN-RELATED PROTEIN 7-SPECIFIC ANTIBODIES AND USES THEREOF | BROADWING BIO LLC (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023212298-A1 | BISPECIFIC ANTIBODIES AND METHODS OF TREATING OCULAR DISEASE | BROADWING BIO LLC (US) | 2023-11-02 | — | — | WO | disclosed |
| EP-4251206-A1 | PROTEIN DERIVATIVES CONTAINING UNNATURAL AMINO ACIDS AND BRANCHED LINKERS | Brickbio, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023173170-A1 | USE OF 4-THIAZOL-N-(PYRIDIN-2-YL)PYRIMIDIN-2-AMINE DERIVATIVES IN COMBINATION THERAPIES FOR CANCER | AUCENTRA THERAPEUTICS PTY LTD (AU) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023173172-A1 | USE OF 5-(2-((5-(4-(DIMETHYLAMINO)PIPERIDIN-1-YL)PYRIDIN-2-YL)AMINO)-5-FLUOROPYRIMIDIN-4-YL)-N,4-DIMETHYLTHIAZOL-2-AMINE IN COMBINATION THERAPIES FOR CANCER | AUCENTRA THERAPEUTICS PTY LTD (AU) | 2023-09-21 | — | — | WO | disclosed |
| EP-4228702-A1 | NON-COVALENT PROTEIN-HYALURONAN CONJUGATES FOR LONG-ACTING OCULAR DELIVERY | F. Hoffmann-La Roche AG (CH) | 2023-08-23 | — | — | EP | disclosed |
| WO-2006092574-A1 | INDOLYLAMINO QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006064217-A2 | PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| WO-2006051270-A1 | 5-HETEROARYL THIAZOLES AND THEIR USE AS P13K INHIBITORS | ASTRAZENECA AB (SE) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006040522-A1 | QUINOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2006-04-20 | — | — | WO | disclosed |
| WO-2006018628-A1 | ENANTIOMERS OF SELECTED FUSED PYRIMIDONES AND USES IN THE TREATMENT AND PREVENTI ON OF CANCER | ASTRAZENECA AB (SE) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006008523-A1 | FUSED PYRIMIDONES USEFUEL IN THE TREATMENT AND THE PREVENTION OF CANCER | ASTRAZENECA AB (SE) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006005918-A1 | 2, 4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2006-01-19 | — | — | WO | disclosed |
| WO-2006005915-A1 | 2, 4, 6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2006-01-19 | — | — | WO | disclosed |
| WO-2005117888-A1 | COMBINATION PRODUCT COMPRISING SRC KINASE INHIBITOR AZDO530 AND AN ANTIOESTROGEN OR EGFR-TK-INHIBITOR | ASTRAZENECA AB (SE) | 2005-12-15 | — | — | WO | disclosed |